M. N. Bizot

Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers

Sujata Vaidyanathan, Jessica Valencia, Charisse Kemp et al. · International Journal of Clinical Practice · 2006 · 87 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Blood Concentrations of Everolimus Are Markedly Increased by Ketoconazole

John M. Kovarik, D. Beyer, M. N. Bizot et al. · The Journal of Clinical Pharmacology · 2005 · 80 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Pharmacokinetic interaction between verapamil and everolimus in healthy subjects

John M. Kovarik, D. Beyer, M. N. Bizot et al. · British Journal of Clinical Pharmacology · 2005 · 54 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Effect of multiple-dose erythromycin on everolimus pharmacokinetics

John M. Kovarik, D. Beyer, M. N. Bizot et al. · European Journal of Clinical Pharmacology · 2005 · 41 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Effect of aliskiren, an oral direct renin inhibitor, on the pharmacokinetics and pharmacodynamics of a single dose of acenocoumarol in healthy volunteers

Haihong Huang, Sujata Vaidyanathan, C YEH et al. · Current Medical Research and Opinion · 2008 · 10 citations

Medicine, Pharmacokinetics, Pharmacology +13